Research Directory Details | National Medical Research Register

Synchronous Multiple Primary Malignancies (MPMs) of breast cancer and Diffused Large B Cell Lymphoma : case report

Synchronous Multiple Primary Malignancies (MPMs) of breast cancer and Diffused Large B Cell Lymphoma : case report

multiple cancer, lymphoma,breast cancer

General Information
NMRR ID
NMRR-21-980-60093
Date of NMRR Registration
30/05/2021 11:20:44
Type of Submission
Investigator Initiated Research (IIR)
Protocol ID
Research Scope
Case Study / Report / Clinical Audit
Research Type
Clinical Audit / Quality Assurance / Quality Control
Study Information
RMK Priority Area
Research Area

Disease Area


Investigational Product/ Process /Intervention
Research Level
Research Description/ Research Lay Summary
this is a rare case where 2 pathology was occurring in a patient where diagnostic challenge on getting biopsy for non feasible lymph nodes location.
research on treatment option that can cure both disease.
Research Keyword
synchronous multiple primary malignancy, lymphoma, breast cancer
Research Objective
a case report to highlight regarding a rare incident of synchronous occurrence of breast cancer and diffuse large B cell lymphoma and diagnostic dilemma of lymphoma in non feasible biopsy to be obtained.
Inclusion & Exclusion Criteria
Inclusion Criteria
Exclusion Criteria
Study Timeline
Expected / Actual Date Study Starts - First Enrolment of subject / Collecting data
May, 31 2021
Expected / Actual Date Study Completed
Jun, 30 2021
Expected / Actual Duration of Study Enrollment / Data Collection
4 weeks
Subject (Sample Size) Description
Age Range :
Gender :
Outcome Measure
-


Biospecimen Collection & Archiving
-


Current Study Status
Sites
Sites Description
No. of site :
Sites List
HOSPITAL TUANKU FAUZIAH, KANGAR
Team Members
Principal Investigator Information
Irma Liyana Binti Mushaddik
HOSPITAL TUANKU FAUZIAH, KANGAR
Sponsor
HOSPITAL TUANKU FAUZIAH, KANGARHOSPITAL TUANKU FAUZIAH, KANGAR
Ethical Application Status
Study URL
-
-
Individual Clinical Trial Participant–level Data of Individual Participant Data (IPD) Sharing
Result Summary